Event Type
Disclosure
Voluntary
Variant
8-K
and Exhibit 99.1 attached hereto are furnished and shall not be deemed to be “filed” with the Securities and Exchange Commission (the “SEC”) for purposes of Sec
. Other Events. Announcement of Application for Breakthrough Medicine Designation with the SFDA for QRX003 On January 20, 2026, the Company announced that it ha
. Financial Statements and Exhibits. (d) Exhibits. The following exhibits are filed or furnished, as applicable, with this Report: Exhibit Number Description 99